Total Debt Summary of Hybio Pharmaceutical Co., Ltd.

Hybio Pharmaceutical Co., Ltd.'s latest annual total debt in 2023 was 2 Billion CNY , up 11.75% from previous year.
Hybio Pharmaceutical Co., Ltd.'s latest quarterly total debt in 2024 Q3 was 1.5 Billion CNY , down -15.03% from previous quarter.
Hybio Pharmaceutical Co., Ltd. reported annual total debt of 1.79 Billion CNY in 2022, up 0.69% from previous year.
Hybio Pharmaceutical Co., Ltd. reported annual total debt of 1.78 Billion CNY in 2021, down -8.23% from previous year.
Hybio Pharmaceutical Co., Ltd. reported quarterly total debt of 1.7 Billion CNY for 2024 Q1, down -15.13% from previous quarter.
Hybio Pharmaceutical Co., Ltd. reported quarterly total debt of 1.77 Billion CNY for 2024 Q2, up 4.05% from previous quarter.

Annual Total Debt Chart of Hybio Pharmaceutical Co., Ltd. (2023 - 2007)

Historical Annual Total Debt of Hybio Pharmaceutical Co., Ltd. (2023 - 2007)

Year	Total Debt	Total Debt Growth
2023	2 Billion CNY	11.75%
2022	1.79 Billion CNY	0.69%
2021	1.78 Billion CNY	-8.23%
2020	1.94 Billion CNY	-4.0%
2019	2.02 Billion CNY	14.65%
2018	1.76 Billion CNY	128.15%
2017	774.84 Million CNY	85.48%
2016	417.74 Million CNY	-16.07%
2015	497.75 Million CNY	150.43%
2014	198.75 Million CNY	0.0%
2013	- CNY	0.0%
2012	- CNY	0.0%
2011	- CNY	0.0%
2010	- CNY	-100.0%
2009	29 Million CNY	0.0%
2008	- CNY	0.0%
2007	- CNY	0.0%

Year	Total Debt	Total Debt Growth
2024 Q3	1.5 Billion CNY	-15.03%
2024 Q1	1.7 Billion CNY	-15.13%
2024 Q2	1.77 Billion CNY	4.05%
2023 Q2	1.74 Billion CNY	-3.71%
2023 Q3	1.73 Billion CNY	-0.49%
2023 FY	2 Billion CNY	11.75%
2023 Q4	2 Billion CNY	15.52%
2023 Q1	1.81 Billion CNY	0.96%
2022 Q1	1.79 Billion CNY	0.27%
2022 Q4	1.79 Billion CNY	0.43%
2022 Q2	1.82 Billion CNY	1.91%
2022 FY	1.79 Billion CNY	0.69%
2022 Q3	1.79 Billion CNY	-1.89%
2021 Q3	1.8 Billion CNY	-0.98%
2021 Q1	2.19 Billion CNY	12.98%
2021 Q2	1.81 Billion CNY	-17.23%
2021 FY	1.78 Billion CNY	-8.23%
2021 Q4	1.78 Billion CNY	-0.89%
2020 Q4	1.94 Billion CNY	10.32%
2020 FY	1.94 Billion CNY	-4.0%
2020 Q1	2.02 Billion CNY	-0.15%
2020 Q2	1.93 Billion CNY	-4.57%
2020 Q3	1.76 Billion CNY	-8.67%
2019 FY	2.02 Billion CNY	14.65%
2019 Q1	1.85 Billion CNY	4.73%
2019 Q2	2.17 Billion CNY	17.3%
2019 Q3	2.22 Billion CNY	2.64%
2019 Q4	2.02 Billion CNY	-9.08%
2018 Q4	1.76 Billion CNY	30.9%
2018 FY	1.76 Billion CNY	128.15%
2018 Q3	1.35 Billion CNY	21.78%
2018 Q2	1.1 Billion CNY	-14.02%
2018 Q1	1.28 Billion CNY	66.46%
2017 Q2	405.06 Million CNY	-2.82%
2017 Q1	416.79 Million CNY	-0.23%
2017 FY	774.84 Million CNY	85.48%
2017 Q4	774.84 Million CNY	34.51%
2017 Q3	576.03 Million CNY	42.21%
2016 FY	417.74 Million CNY	-16.07%
2016 Q2	699.64 Million CNY	15.1%
2016 Q1	607.87 Million CNY	22.12%
2016 Q3	648.69 Million CNY	-7.28%
2016 Q4	417.74 Million CNY	-35.6%
2015 Q3	437.62 Million CNY	9.71%
2015 Q1	198.81 Million CNY	0.03%
2015 FY	497.75 Million CNY	150.43%
2015 Q4	497.75 Million CNY	13.74%
2015 Q2	398.9 Million CNY	100.64%
2014 Q3	198.7 Million CNY	0.03%
2014 FY	198.75 Million CNY	0.0%
2014 Q1	- CNY	0.0%
2014 Q4	198.75 Million CNY	0.02%
2014 Q2	198.64 Million CNY	0.0%
2013 Q2	- CNY	0.0%
2013 FY	- CNY	0.0%
2013 Q4	- CNY	0.0%
2013 Q3	- CNY	0.0%
2013 Q1	- CNY	0.0%
2012 Q4	- CNY	0.0%
2012 FY	- CNY	0.0%
2012 Q1	- CNY	0.0%
2012 Q2	- CNY	0.0%
2012 Q3	- CNY	0.0%
2011 Q4	- CNY	0.0%
2011 Q2	- CNY	0.0%
2011 Q1	- CNY	0.0%
2011 Q3	- CNY	0.0%
2011 FY	- CNY	0.0%
2010 Q2	29 Million CNY	0.0%
2010 FY	- CNY	-100.0%
2010 Q4	- CNY	0.0%
2009 FY	29 Million CNY	0.0%
2008 FY	- CNY	0.0%
2007 FY	- CNY	0.0%

Peer Total Debt Comparison of Hybio Pharmaceutical Co., Ltd.

Name	Total Debt	Total Debt Difference
Shenzhen Kangtai Biological Products Co., Ltd.	2.54 Billion CNY	21.103%
PharmaBlock Sciences (Nanjing), Inc.	1.82 Billion CNY	-9.793%
Shandong Shanda Wit Science and Technology Co., Ltd.	66.95 Thousand CNY	-3000644.424%
Pacific Shuanglin Bio-pharmacy Co., LTD	496.01 Million CNY	-305.054%
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd	1.7 Billion CNY	-17.636%
Jilin Aodong Pharmaceutical Group Co., Ltd.	3.03 Billion CNY	33.741%
Chengdu Huasun Technology Group Inc., Ltd.	415.33 Million CNY	-383.746%
Zhejiang AngLiKang Pharmaceutical CO.,LTD.	587.75 Million CNY	-241.834%
Hengkang Medical Group Co., Ltd.	2.05 Billion CNY	2.321%
Anhui Huangshan Capsule Co., Ltd.	81.46 Million CNY	-2366.293%
Walvax Biotechnology Co., Ltd.	839.07 Million CNY	-139.447%
Tianjin Ringpu Bio-Technology Co.,Ltd.	872.07 Million CNY	-130.387%
Anhui Fengyuan Pharmaceutical Co., Ltd.	687.76 Million CNY	-192.128%
Apeloa Pharmaceutical Co.,Ltd	3.42 Billion CNY	41.367%
Harbin Gloria Pharmaceuticals Co., Ltd	674.86 Million CNY	-197.713%
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.	3.94 Billion CNY	49.036%
Hunan Hansen Pharmaceutical Co., Ltd.	109.44 Million CNY	-1735.683%
Xiamen Kingdomway Group Company	894.08 Million CNY	-124.716%
Zhejiang Tianyu Pharmaceutical Co., Ltd.	1.79 Billion CNY	-11.699%
Zhuhai Rundu Pharmaceutical Co., Ltd.	572.82 Million CNY	-250.745%
Hainan Haiyao Co., Ltd.	3.36 Billion CNY	40.254%
Shenzhen Neptunus Bioengineering Co., Ltd.	11.39 Billion CNY	82.373%
Fujian Cosunter Pharmaceutical Co., Ltd.	459.26 Million CNY	-337.468%
Huapont Life Sciences Co., Ltd.	8.62 Billion CNY	76.708%
Livzon Pharmaceutical Group Inc.	5.03 Billion CNY	60.105%
Honz Pharmaceutical Co., Ltd.	501.63 Million CNY	-300.517%
Northeast Pharmaceutical Group Co., Ltd.	6.91 Billion CNY	70.93%
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	5.56 Billion CNY	63.883%
Hainan Poly Pharm. Co., Ltd	2.42 Billion CNY	17.187%
Sunflower Pharmaceutical Group Co.,Ltd	30.06 Million CNY	-6582.425%
Zhejiang Jingxin Pharmaceutical Co., Ltd.	652.48 Million CNY	-207.92%
Kunming Longjin Pharmaceutical Co., Ltd.	983.62 Thousand CNY	-204158.763%
Zhejiang Hisoar Pharmaceutical Co., Ltd.	1.05 Billion CNY	-90.709%
Zhejiang Yatai Pharmaceutical Co., Ltd.	689.53 Million CNY	-191.377%
Zhejiang NHU Company Ltd.	9.62 Billion CNY	79.13%
Zhejiang Xinguang Pharmaceutical Co., Ltd.	- CNY	-Infinity%
Jiuzhitang Co., Ltd.	185.85 Million CNY	-981.003%
Qianjiang Yongan Pharmaceutical Co., Ltd.	47.3 Million CNY	-4147.142%
Jinghua Pharmaceutical Group Co., Ltd.	36 Million CNY	-5480.686%
Hunan Er-Kang Pharmaceutical Co., Ltd	362.61 Million CNY	-454.072%
Yunnan Baiyao Group Co.,Ltd	3.84 Billion CNY	47.778%
ApicHope Pharmaceutical Co., Ltd	802.42 Million CNY	-150.384%
Shandong Wohua Pharmaceutical Co., Ltd.	2.72 Million CNY	-73572.334%
Jinling Pharmaceutical Company Limited	4.81 Million CNY	-41629.272%
Beijing SL Pharmaceutical Co., Ltd.	37.59 Million CNY	-5244.435%
Shanxi Zhendong Pharmaceutical Co.,Ltd	2.85 Million CNY	-70290.159%
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd	102.49 Million CNY	-1860.266%
Huaren Pharmaceutical Co., Ltd.	1.88 Billion CNY	-6.79%
Betta Pharmaceuticals Co., Ltd.	2.42 Billion CNY	17.244%
Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD	144.54 Million CNY	-1290.024%
Changzhou Qianhong Biopharma CO.,LTD	56.1 Million CNY	-3481.302%
Chengdu Kanghong Pharmaceutical Group Co., Ltd	2.01 Million CNY	-99792.281%
Changjiang Pharmaceutical Group Co., Ltd.	837.48 Million CNY	-139.902%
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd.	297.59 Million CNY	-575.121%
Zhejiang Garden Bio-chemical High-tech Co., Ltd.	1.67 Billion CNY	-19.607%
Tianjin Lisheng Pharmaceutical Co.,Ltd.	63.03 Million CNY	-3087.333%
Guangdong Lifestrong Pharmacy Co., Ltd.	13.95 Million CNY	-14298.903%
Huadong Medicine Co., Ltd	3.74 Billion CNY	46.339%
PKU HealthCare Corp.,Ltd.	82.13 Million CNY	-2346.077%
Shenzhen Weiguang Biological Products Co., Ltd.	525.39 Million CNY	-282.405%
Fuan Pharmaceutical (Group) Co., Ltd.	892.85 Million CNY	-125.025%
Jiangsu Nhwa Pharmaceutical Co., LTD	172.55 Million CNY	-1064.328%
Harbin Medisan Pharmaceutical Co., Ltd.	718.37 Million CNY	-179.679%
Teyi Pharmaceutical Group Co.,Ltd	347.15 Million CNY	-478.753%
Tus-Pharmaceutical Group Co., Ltd.	133.69 Million CNY	-1402.795%
LanZhou Foci Pharmaceutical Co.,Ltd.	26.03 Million CNY	-7618.137%
Changchun High-Tech Industries (Group) Inc.	1.7 Billion CNY	-17.661%
Shanghai Kaibao Pharmaceutical CO.,Ltd	4.28 Million CNY	-46781.654%
Shandong Xinhua Pharmaceutical Company Limited	1.87 Billion CNY	-7.203%
Beijing Beilu Pharmaceutical Co., Ltd	791.33 Million CNY	-153.893%
Dezhan Healthcare Company Limited	7.57 Million CNY	-26429.772%
Beijing Science Sun Pharmaceutical Co., Ltd.	- CNY	-Infinity%
Tianjin Chase Sun Pharmaceutical Co.,Ltd	1.53 Billion CNY	-31.026%
Beijing Aosaikang Pharmaceutical Co., Ltd.	123.8 Million CNY	-1522.895%
Jinhe Biotechnology CO., LTD.	2.29 Billion CNY	12.639%
Baotou Dongbao Bio-Tech Co.,Ltd	469.28 Million CNY	-328.132%
ShanXi C&Y Pharmaceutical Group Co., Ltd.	393.81 Million CNY	-410.181%
Tibet AIM Pharm. Inc.	11.01 Million CNY	-18147.466%
Guangdong Zhongsheng Pharmaceutical Co., Ltd.	724.6 Million CNY	-177.276%
Nanjing Hicin Pharmaceutical Co., Ltd.	299.44 Million CNY	-570.969%
Renhe Pharmacy Co., Ltd.	18.49 Million CNY	-10761.973%
Wuhan Hiteck Biological Pharma Co.,Ltd	65.95 Million CNY	-2946.21%
Guizhou Xinbang Pharmaceutical Co., Ltd.	1.08 Billion CNY	-85.362%
Dong-E-E-Jiao Co.,Ltd.	51.28 Million CNY	-3817.595%
Jiangxi Synergy Pharmaceutical Co., Ltd.	768.95 Million CNY	-161.281%
Chongqing Pharscin Pharmaceutical Co., Ltd.	281.95 Thousand CNY	-712470.109%
Zhejiang Xianju Pharmaceutical Co.,Ltd.	445.55 Million CNY	-350.929%
Luoxin Pharmaceuticals Group Stock Co., Ltd.	1.52 Billion CNY	-32.154%
Guizhou Bailing Group Pharmaceutical Co., Ltd.	1.71 Billion CNY	-17.249%

Global Stocks Search

Hybio Pharmaceutical Co., Ltd. (300199.SZ)

Total Debt Summary of Hybio Pharmaceutical Co., Ltd.

Annual Total Debt Chart of Hybio Pharmaceutical Co., Ltd. (2023 - 2007)

Historical Annual Total Debt of Hybio Pharmaceutical Co., Ltd. (2023 - 2007)

Peer Total Debt Comparison of Hybio Pharmaceutical Co., Ltd.